ATAI
Price
$3.88
Change
-$0.13 (-3.24%)
Updated
Aug 15 closing price
Capitalization
823.12M
92 days until earnings call
QNTM
Price
$22.45
Change
+$0.10 (+0.45%)
Updated
Aug 15 closing price
Capitalization
81.84M
Interact to see
Advertisement

ATAI vs QNTM

Header iconATAI vs QNTM Comparison
Open Charts ATAI vs QNTMBanner chart's image
ATAI Life Sciences
Price$3.88
Change-$0.13 (-3.24%)
Volume$6.69M
Capitalization823.12M
Quantum Biopharma
Price$22.45
Change+$0.10 (+0.45%)
Volume$121.61K
Capitalization81.84M
ATAI vs QNTM Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. QNTM commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (ATAI: $3.88 vs. QNTM: $22.45)
Brand notoriety: ATAI and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 108% vs. QNTM: 45%
Market capitalization -- ATAI: $823.12M vs. QNTM: $81.84M
ATAI [@Biotechnology] is valued at $823.12M. QNTM’s [@Biotechnology] market capitalization is $81.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 2 TA indicator(s) are bullish while QNTM’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 2 bullish, 6 bearish.
  • QNTM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, QNTM is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -6.05% price change this week, while QNTM (@Biotechnology) price change was -23.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

ATAI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($823M) has a higher market cap than QNTM($81.8M). QNTM YTD gains are higher at: 510.054 vs. ATAI (191.729). QNTM has higher annual earnings (EBITDA): -20.68M vs. ATAI (-145.09M). ATAI has more cash in the bank: 98.2M vs. QNTM (3.54M). QNTM has less debt than ATAI: QNTM (1.28M) vs ATAI (26.7M). ATAI has higher revenues than QNTM: ATAI (1.86M) vs QNTM (0).
ATAIQNTMATAI / QNTM
Capitalization823M81.8M1,006%
EBITDA-145.09M-20.68M702%
Gain YTD191.729510.05438%
P/E RatioN/AN/A-
Revenue1.86M0-
Total Cash98.2M3.54M2,775%
Total Debt26.7M1.28M2,086%
FUNDAMENTALS RATINGS
ATAI vs QNTM: Fundamental Ratings
ATAI
QNTM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (72) in the Miscellaneous Commercial Services industry is in the same range as QNTM (78) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's Profit vs Risk Rating (87) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as ATAI (35) in the Miscellaneous Commercial Services industry. This means that QNTM’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's P/E Growth Rating (13) in the Miscellaneous Commercial Services industry is significantly better than the same rating for QNTM (100) in the null industry. This means that ATAI’s stock grew significantly faster than QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIQNTM
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPIAX15.270.08
+0.53%
Timothy Plan International A
RYBMX76.56-0.06
-0.08%
Rydex Basic Materials A
JAAGX80.75-0.09
-0.11%
Janus Henderson VIT Enterprise Instl
PJVQX24.10-0.11
-0.45%
PGIM Jennison Value R6
BPTRX201.78-1.16
-0.57%
Baron Partners Retail

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-3.24%
MNMD - ATAI
50%
Loosely correlated
-1.13%
RXRX - ATAI
44%
Loosely correlated
+2.30%
CYBN - ATAI
42%
Loosely correlated
-1.53%
CRSP - ATAI
42%
Loosely correlated
+1.55%
ABSI - ATAI
41%
Loosely correlated
-2.33%
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+0.45%
HYPD - QNTM
34%
Loosely correlated
+7.62%
AZTR - QNTM
26%
Poorly correlated
+7.05%
CPIX - QNTM
26%
Poorly correlated
+4.68%
MNMD - QNTM
25%
Poorly correlated
-1.13%
ATAI - QNTM
25%
Poorly correlated
-3.24%
More